First Report of Outcomes from the Patient-reported Outcome Measures Program in the Metabolic and Bariatric Surgery Accreditation Quality Improvement Program
Health-related quality-of-life (HRQoL) is one of the most important outcomes to metabolic and bariatric surgery (MBS) patients but was not measured by the Metabolic and Bariatric Surgery Accreditation Quality Improvement Program (MBSAQIP). A Patient-reported Outcome Measures (PROMs) Program pilot started in 2016 with MBSAQIP implementation in 2019. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 14, 2023 Category: Surgery Authors: Meridith E. Greene, Arielle Grieco, Kimberly Evans-Labok, Clifford Y. Ko, Matthew M. Hutter Tags: Original articles Source Type: research

Comment on: The burden of abdominal pain after bariatric surgery in terms of diagnostic testing: the OPERATE study
Vink et  al. [1] have contributed to the metabolic and bariatric literature with their study on the need for numerous diagnostic tests to help diagnose the cause of abdominal pain after bariatric operations. It is essential to note that in the authors’ study population of all bariatric patients in a sing le Dutch center over a 1-year time period (December 2020–December 2021), 86% of patients underwent Roux-en-Y gastric bypass. This is a significantly higher percentage than is seen in most U.S. bariatric programs, which tend to be sleeve heavy [2]. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 11, 2023 Category: Surgery Authors: Ann M. Rogers Tags: Editorial comment Source Type: research

Comment on: Perceptions of bariatric surgery in patients with type 2  diabetes—data from a self-administered questionnaire
Obesity and type 2 diabetes (T2D) are closely linked [1]. The majority of patients with T2D are overweight or have obesity, and obesity is a major risk factor for T2D, diabetes-related micro- and macrovascular complications, and other associated conditions such as obstructive sleep apnea and nonalcoholic fatty liver disease [1]. As a result, it is not surprising that weight loss has a major favorable impact on a wide range of diabetes-related outcomes from improvement in glycemic control to T2D remission to reduction of the burden of complications and improved quality of life and survival [1,2]. (Source: Surgery for Obesit...
Source: Surgery for Obesity and Related Diseases - September 11, 2023 Category: Surgery Authors: Adb A. Tahrani Tags: Editorial comment Source Type: research

Comment on: The burden of abdominal pain after bariatric surgery in terms of diagnostic testing
Vink et al. have contributed to the metabolic and bariatric literature with their study on the need for numerous diagnostic tests to help diagnose the cause of abdominal pain after bariatric operations.1 It is essential to note that in the authors ’ study population of all bariatric patients in a single Dutch center over a one-year time period (December 2020 to December 2021), 86% of patients underwent Roux-en-Y gastric bypass. This is a significantly higher percentage than is seen in most US bariatric programs, which tend to be sleeve-heav y. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 11, 2023 Category: Surgery Authors: Ann M. Rogers Source Type: research

Comment on: Perceptions of bariatric surgery in patients with T2DM: Data from a self-administered questionnaire
AAT reports the following: Grants from Novo Nordisk and Sanofi; personal fees from Novo Nordisk, Janssen, AZ, Eli Lilly, BI, BMS, NAPP, MSD, Nestle, Gilead, Sanofi; as well as non-financial support from Novo Nordisk, Eli Lilly, AZ, Impeto medical, Resmed, Aptiva, BI, BMS, NAPP, MSD. AAT is currently an employee of Novo Nordisk A/S but Novo Nordisk A/S had no involvement in this work. The views detailed in this editorial are those of the author and not those of any of the employers or the funders. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 11, 2023 Category: Surgery Authors: Adb A. Tahrani Source Type: research

Cannabis Use following Bariatric Surgery is associated with Anxiety and Maladaptive Eating
There are limited data regarding the association of cannabis use with outcomes after bariatric surgery. As such, it is challenging to know how to counsel patients using cannabis. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 11, 2023 Category: Surgery Authors: Lisa R. Miller-Matero, Kaitlin Ross, Camila Arellano, Logan Zelenak, Eve DePascale, Lyubov Gavrilova, Jordan M. Braciszewski, Leah M. Hecht, Erin N. Haley, Carly Brescacin, Arthur M. Carlin Tags: Integrated Health Article Source Type: research

Comment on: Perceptions of bariatric surgery in patients with type 2  diabetes: data from a self-administered questionnaire
In 1991, the National Institutes of Health (NIH) convened a consensus development conference to establish the criteria and surgical treatment for patients with severe obesity [1]. Integral to the consensus statement is the association of obesity with chronic medical conditions, including type 2 diabetes (T2D) [2]. In fact, some studies report that up to 80% of patients with T2D also have obesity [3]. In addition to T2D, obesity has been found to be associated with many other chronic medical conditions, including cardiovascular disease, musculoskeletal disease, and even some cancers. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 9, 2023 Category: Surgery Authors: Ivy N. Haskins Tags: Editorial comment Source Type: research

Comment on: Investigation of the effect of weight loss after laparoscopic sleeve gastrectomy on Cobb angle, low back, and back pain: a prospective study
We read with great interest the article titled “Investigation of the effect of weight loss after laparoscopic sleeve gastrectomy on Cobb angle, low back, and back pain: a prospective study.” Ergin et al. assessed the correlation between weight loss and improvements in parameters of musculoskeletal spinal conditions in 89 patients undergoing sleeve gastrectomy (SG).1 Specific measurements included patient-reported outcomes (Visual Analogue Scale, Oswestry Low Back Pain Disability Questionnaire, Roland-Morris Disability Questionnaire, and SF-36 Quality of Life Questionnaire) and the Cobb angle, a radiographic measurement...
Source: Surgery for Obesity and Related Diseases - September 9, 2023 Category: Surgery Authors: Ina Chen, Jerry T. Dang Source Type: research

Comment on: Short-term Cardiovascular Events After Bariatric Surgery in Patients with Metabolic Syndrome
Metabolic surgeons are familiar with operating on patients with a plethora of obesity-associated medical conditions. “Metabolic syndrome” is a term commonly used in the care of the patient living with obesity and, while metabolic syndrome comprises several associated conditions (i.e. abdominal adiposity, hypertension, hyperlipidemia/dyslipidemia, and impaired fasting glucose), identifying the contributing fact ors of each to operative risk remains challenging. Fortunately, the Metabolic and Bariatric Surgery Quality Improvement Project (MBSAQIP) is the largest collection of bariatric surgery specific data available, wh...
Source: Surgery for Obesity and Related Diseases - September 9, 2023 Category: Surgery Authors: Vance L. Albaugh Source Type: research

Comment on: Glycemic Variability and Hypoglycemia before and after Roux-en-Y Gastric Bypass and Sleeve Gastrectomy – a cohort study of females without diabetes
Wearable devices and monitoring all sorts of personal biologic data from temperature to heart rate to blood oxygen saturation has become increasingly common, especially with the focus of monitoring data for health and fitness purposes. From the metabolic surgeon ’s perspective, continuous glucose monitoring has also become increasingly prevalent – even in our patients without diabetes. While post-bariatric hypoglycemia has been a long-standing complication of surgical weight loss, clinically significant hypoglycemia appears to affect a small portion of surgical patients. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 9, 2023 Category: Surgery Authors: Vance L. Albaugh Source Type: research

Comment on: Perceptions of Bariatric Surgery in Patients with T2DM: Data from a Self-Administered Questionnaire
In 1991, the National Institutes of Health convened a Consensus Development Conference to establish the criteria and surgical treatment for severe obesity.1 Integral to the consensus statement is the association of obesity with chronic medical conditions, including type 2 diabetes mellitus (T2DM).2 In fact, some studies report that up to 80% of patients with T2DM are also obese.3 In addition to T2DM, obesity has been found to be associated with many other chronic medical conditions, including cardiovascular disease, musculoskeletal disease, and even some cancers. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 9, 2023 Category: Surgery Authors: Ivy N. Haskins Source Type: research

Preoperative medically supervised weight loss programs and weight loss outcomes following bariatric surgery – a prospective analysis
Prior to undergoing bariatric surgery, many insurance companies require patients to attend medically supervised weight management visits for 3 –6 months to be eligible for surgery. There have been few studies that have looked specifically at the relationship between medically supervised weight management visit attendance and postoperative outcomes, and the current literature reports discrepant findings. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 7, 2023 Category: Surgery Authors: Eliane Shinder, Paris Hanson, Hannah Phillips, Catherine Tuppo, Konstantinos Spaniolas, Aurora Pryor, Kinga Powers, Caroline Sanicola, Genna Hymowitz Tags: Original article Source Type: research

Pre-operative medically supervised weight loss programs and weight loss outcomes following bariatric surgery – a prospective analysis
Prior to undergoing bariatric surgery, many insurance companies require patients to attend medically supervised weight management visits for 3-6 months to be eligible for surgery. There have been few studies that have looked specifically at the relationship between medically supervised weight management visit attendance and post-operative outcomes, and the current literature reports discrepant findings. (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 7, 2023 Category: Surgery Authors: Eliane Shinder, Paris Hanson, Hannah Phillips, Catherine Tuppo, Konstantinos Spaniolas, Aurora Pryor, Kinga Powers, Caroline Sanicola, Genna Hymowitz Tags: Original articles Source Type: research

Benefits of metabolic surgery on macrovascular outcomes in adult patients with type 2 diabetes: a systematic review and meta-analysis
Type 2 diabetes (T2D) is a chronic metabolic disorder that affects millions of individuals associated with an increased risk of mortality and macrovascular complications. We aimed to synthesize the benefit of metabolic surgery (MS) on macrovascular outcomes in adult patients with T2D.We included both cohort studies and randomized controlled trials (RCTs) that evaluated MS added to medical therapy compared with medical therapy alone in the treatment of adult patients with T2D. Studies must have evaluated the incidence of any macrovascular complication of the disease for a period of at least 6 months. (Source: Surgery for Ob...
Source: Surgery for Obesity and Related Diseases - September 6, 2023 Category: Surgery Authors: Javier Obeso-Fern ández, Juan Manuel Millan-Alanis, Melissa Sáenz-Flores, Mario Rodríguez-Bautista, Samantha Medrano-Juarez, Stephie Oyervides-Fuentes, Daniela Gonzalez-Cruz, Dulce Maria Manzanares-Gallegos, José Gerardo González-González, René Rod Tags: Review article Source Type: research

Benefits of metabolic surgery on macrovascular outcomes in adult patients with type 2 diabetes- A Systematic review and meta-analysis
Type 2 diabetes (T2D) is a chronic metabolic disorder that affects millions of individuals associated with an increased risk of mortality and macrovascular complications. We aimed to synthesize the benefit of metabolic surgery (MS) on macrovascular outcomes in adult patients with T2D (Source: Surgery for Obesity and Related Diseases)
Source: Surgery for Obesity and Related Diseases - September 6, 2023 Category: Surgery Authors: Javier Obeso-Fern ández, Juan Manuel Millan-Alanis, Melissa Sáenz-Flores, Mario Rodríguez-Bautista, Samantha Medrano-Juarez, Stephie Oyervides-Fuentes, Dulce Daniela Gonzalez-Cruz, Dulce Maria Manzanares-Gallegos, José Gerardo González-González, Ren Source Type: research